Home > Insider Trading > Filing (0001209191-22-034895)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1538210	Neximmune Inc.	NEXI	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1843817	Grant Verstandig	C/O Neximmune, Inc. 9119 Gaither Road Gaithersburg MD 20877		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-06-07	26,876	$2.28	1,105,495	No	4	P	Direct
Common Stock	Acquisiton	2022-06-06	25,000	$2.14	1,078,619	No	4	P	Direct
Common Stock	Acquisiton	2022-06-03	15,000	$2.22	1,053,619	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	P	Direct
No	4	P	Direct
No	4	P	Direct

Footnotes

The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.14 to $2.45, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
Excludes 17,376 shares of common stock underlying options that are currently exercisable.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.06 to $2.28, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.
The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.13 to $2.30, inclusive. The reporting person will provide to the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares purchased at each separate price.